125 related articles for article (PubMed ID: 23241526)
41. Prognostic importance of PAI-1 in node negative breast cancer patients--results after 10 years of follow up.
Eljuga D; Razumovic JJ; Bulic K; Petrovecki M; Draca N; Bulic SO
Pathol Res Pract; 2011 May; 207(5):290-4. PubMed ID: 21459526
[TBL] [Abstract][Full Text] [Related]
42. Breast-conserving surgery versus mastectomy for survival from breast cancer: the Western Australian experience.
Martin MA; Meyricke R; O'Neill T; Roberts S
Ann Surg Oncol; 2007 Jan; 14(1):157-64. PubMed ID: 17058124
[TBL] [Abstract][Full Text] [Related]
43. Application of accelerated failure time models for breast cancer patients' survival in Kurdistan Province of Iran.
Karimi A; Delpisheh A; Sayehmiri K
J Cancer Res Ther; 2016; 12(3):1184-1188. PubMed ID: 28054533
[TBL] [Abstract][Full Text] [Related]
44. Survival analysis in gastric cancer: a multi-center study among Iranian patients.
Talebi A; Mohammadnejad A; Akbari A; Pourhoseingholi MA; Doosti H; Moghimi-Dehkordi B; Agah S; Bahardoust M
BMC Surg; 2020 Jul; 20(1):152. PubMed ID: 32660458
[TBL] [Abstract][Full Text] [Related]
45. Breast cancer survival and health iniquities.
Guerra MR; Silva GA; Nogueira MC; Leite IC; Oliveira Rde V; Cintra JR; Bustamante-Teixeira MT
Cad Saude Publica; 2015 Aug; 31(8):1673-84. PubMed ID: 26375646
[TBL] [Abstract][Full Text] [Related]
46. Survival Prognostic Factors of Male Breast Cancer in Southern Iran: a LASSO-Cox Regression Approach.
Shahraki HR; Salehi A; Zare N
Asian Pac J Cancer Prev; 2015; 16(15):6773-7. PubMed ID: 26434910
[TBL] [Abstract][Full Text] [Related]
47. Prognostic Factors of Breast Cancer Survival in the Islamic Republic of Iran: an Additive Empirical Bayesian Approach.
Nematolahi S; Rezaianzadeh A; Zare N; Akrami M; Tahmasebi S
East Mediterr Health J; 2018 Jan; 23(11):721-728. PubMed ID: 29319143
[TBL] [Abstract][Full Text] [Related]
48. Modeling of breast cancer prognostic factors using a parametric log-logistic model in Fars province, Southern Iran.
Zare N; Doostfatemeh M; Rezaianzadeh A
Asian Pac J Cancer Prev; 2012; 13(4):1533-7. PubMed ID: 22799361
[TBL] [Abstract][Full Text] [Related]
49. Application of Censored Quantile Regression to Determine Overall Survival Related Factors in Breast Cancer.
Faradmal J; Roshanaei G; Mafi M; Sadighi-Pashaki A; Karami M
J Res Health Sci; 2016; 16(1):36-40. PubMed ID: 27061995
[TBL] [Abstract][Full Text] [Related]
50. Five year survival of women with breast cancer in Yazd.
Fallahzadeh H; Momayyezi M; Akhundzardeini R; Zarezardeini S
Asian Pac J Cancer Prev; 2014; 15(16):6597-601. PubMed ID: 25169494
[TBL] [Abstract][Full Text] [Related]
51. Survival and Trends in Annualized Hazard Function by Age at Diagnosis Among Chinese Breast Cancer Patients Aged ≤40 Years: Case Analysis Study.
Wang J; Luo T; Xiang ZZ; He MM; Zeng YY; Yang T; Wei XY; Yu S; Dai ZL; Xu NY; Tan CF; Liu L
JMIR Public Health Surveill; 2023 Jul; 9():e47110. PubMed ID: 37463020
[TBL] [Abstract][Full Text] [Related]
52. Comparison of Aalen's additive and Cox proportional hazards models for breast cancer survival: analysis of population- based data from British Columbia, Canada.
Abadi A; Saadat S; Yavari P; Bajdik C; Jalili P
Asian Pac J Cancer Prev; 2011; 12(11):3113-6. PubMed ID: 22393999
[TBL] [Abstract][Full Text] [Related]
53. Five year survival of women with breast cancer in Ardabil, north-west of Iran.
Fouladi N; Amani F; Harghi AS; Nayebyazdi N
Asian Pac J Cancer Prev; 2011; 12(7):1799-801. PubMed ID: 22126568
[TBL] [Abstract][Full Text] [Related]
54. Survival Evaluation of Hospitalized COVID-19 Patients with Cox Frailty Approach.
Osmani F; Ziaee M
Disaster Med Public Health Prep; 2022 Aug; 17():e233. PubMed ID: 35979746
[TBL] [Abstract][Full Text] [Related]
55. Survival analysis of 1148 women diagnosed with breast cancer in Southern Iran.
Rezaianzadeh A; Peacock J; Reidpath D; Talei A; Hosseini SV; Mehrabani D
BMC Cancer; 2009 Jun; 9():168. PubMed ID: 19497131
[TBL] [Abstract][Full Text] [Related]
56. Estimation of the cure rate in Iranian breast cancer patients.
Rahimzadeh M; Baghestani AR; Gohari MR; Pourhoseingholi MA
Asian Pac J Cancer Prev; 2014; 15(12):4839-42. PubMed ID: 24998549
[TBL] [Abstract][Full Text] [Related]
57. Investigation of Prognostic Factors of Survival in Breast Cancer Using a Frailty Model: A Multicenter Study.
Yazdani A; Yaseri M; Haghighat S; Kaviani A; Zeraati H
Breast Cancer (Auckl); 2019; 13():1178223419879112. PubMed ID: 31632048
[TBL] [Abstract][Full Text] [Related]
58. Applying Additive Hazards Models for Analyzing Survival in Patients with Colorectal Cancer in Fars Province, Southern Iran.
Madadizadeh F; Ghanbarnejad A; Ghavami V; Zare Bandamiri M; Mohammadianpanah M
Asian Pac J Cancer Prev; 2017 Apr; 18(4):1077-1083. PubMed ID: 28547944
[TBL] [Abstract][Full Text] [Related]
59. Survival Prediction and Feature Selection in Patients with Breast Cancer Using Support Vector Regression.
Goli S; Mahjub H; Faradmal J; Mashayekhi H; Soltanian AR
Comput Math Methods Med; 2016; 2016():2157984. PubMed ID: 27882074
[TBL] [Abstract][Full Text] [Related]
60. Application of Cox and Parametric Survival Models to Assess Social Determinants of Health Affecting Three-Year Survival of Breast Cancer Patients.
Mohseny M; Amanpour F; Mosavi-Jarrahi A; Jafari H; Moradi-Joo M; Davoudi Monfared E
Asian Pac J Cancer Prev; 2016; 17(S3):311-6. PubMed ID: 27165244
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
